Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel R Denmeade

Showing results (31-40 of 155) with videos related to

Pageof 16
Sort By:
Biochemistry|March 14, 2009
Prostate-specific antigen is a "chymotrypsin-like" serine protease with unique P1 substrate specificityAaron M LeBeau, Pratap Singh, John T Isaacs, et al.
Clinical Investigation|November 2, 2012
The unfolding treatment landscape for men with castration-resistant prostate cancerJenny J Kim, Daniel Keizman, Samuel R Denmeade, et al.
Chemistry & Biology|July 19, 2008
Potent and selective peptidyl boronic acid inhibitors of the serine protease prostate-specific antigenAaron M LeBeau, Pratap Singh, John T Isaacs, et al.
Molecular Cancer Therapeutics|May 7, 2009
Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxinAaron M LeBeau, W Nathaniel Brennen, Saurabh Aggarwal, et al.
Biological Chemistry|February 26, 2010
Prostate-specific antigen: an overlooked candidate for the targeted treatment and selective imaging of prostate cancerAaron M LeBeau, Maya Kostova, Charles S Craik, et al.
Asian Journal of Urology|February 19, 2019
Albumin-linked prostate-specific antigen-activated thapsigargin- and niclosamide-based molecular grenades targeting the microenvironment in metastatic castration-resistant prostate cancerEmmanuel S Akinboye, W Nathaniel Brennen, Samuel R Denmeade, et al.
Molecules (Basel, Switzerland)|December 24, 2021
Mipsagargin: The Beginning-Not the End-of Thapsigargin Prodrug-Based Cancer TherapeuticsJohn T Isaacs, William Nathaniel Brennen, Søren Brøgger Christensen, et al.
Cancer Research|September 20, 2006
A dimeric peptide that binds selectively to prostate-specific membrane antigen and inhibits its enzymatic activitySaurabh Aggarwal, Pratap Singh, Ozlem Topaloglu, et al.
Proteins|August 26, 2009
Molecular insights into substrate specificity of prostate specific antigen through structural modelingPratap Singh, Aaron M LeBeau, Hans Lilja, et al.
Biomaterials|May 24, 2005
A combinatorial approach to the selective capture of circulating malignant epithelial cells by peptide ligandsSaurabh Aggarwal, Samuel Janssen, Randy M Wadkins, et al.
Pageof 16

Showing results (31-40 of 155) with videos related to

Sort By:
Pageof 16
Biochemistry|March 14, 2009
Prostate-specific antigen is a "chymotrypsin-like" serine protease with unique P1 substrate specificityAaron M LeBeau, Pratap Singh, John T Isaacs, et al.
Clinical Investigation|November 2, 2012
The unfolding treatment landscape for men with castration-resistant prostate cancerJenny J Kim, Daniel Keizman, Samuel R Denmeade, et al.
Chemistry & Biology|July 19, 2008
Potent and selective peptidyl boronic acid inhibitors of the serine protease prostate-specific antigenAaron M LeBeau, Pratap Singh, John T Isaacs, et al.
Molecular Cancer Therapeutics|May 7, 2009
Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxinAaron M LeBeau, W Nathaniel Brennen, Saurabh Aggarwal, et al.
Biological Chemistry|February 26, 2010
Prostate-specific antigen: an overlooked candidate for the targeted treatment and selective imaging of prostate cancerAaron M LeBeau, Maya Kostova, Charles S Craik, et al.
Asian Journal of Urology|February 19, 2019
Albumin-linked prostate-specific antigen-activated thapsigargin- and niclosamide-based molecular grenades targeting the microenvironment in metastatic castration-resistant prostate cancerEmmanuel S Akinboye, W Nathaniel Brennen, Samuel R Denmeade, et al.
Molecules (Basel, Switzerland)|December 24, 2021
Mipsagargin: The Beginning-Not the End-of Thapsigargin Prodrug-Based Cancer TherapeuticsJohn T Isaacs, William Nathaniel Brennen, Søren Brøgger Christensen, et al.
Cancer Research|September 20, 2006
A dimeric peptide that binds selectively to prostate-specific membrane antigen and inhibits its enzymatic activitySaurabh Aggarwal, Pratap Singh, Ozlem Topaloglu, et al.
Proteins|August 26, 2009
Molecular insights into substrate specificity of prostate specific antigen through structural modelingPratap Singh, Aaron M LeBeau, Hans Lilja, et al.
Biomaterials|May 24, 2005
A combinatorial approach to the selective capture of circulating malignant epithelial cells by peptide ligandsSaurabh Aggarwal, Samuel Janssen, Randy M Wadkins, et al.
Pageof 16